Stockscreener 앱 받기
2.23
0.00%
0.00
시간 외 거래:
2.29
0.06
+2.69%
전일 마감가:
$2.23
열려 있는:
$2.23
하루 거래량:
407.51K
Relative Volume:
1.49
시가총액:
$191.78M
수익:
$25.14M
순이익/손실:
$-21.57M
주가수익비율:
-8.2593
EPS:
-0.27
순현금흐름:
$-12.23M
1주 성능:
-0.89%
1개월 성능:
+9.31%
6개월 성능:
+1.83%
1년 성능:
+12.06%
1일 변동 폭
$2.21
$2.28
1주일 범위
$2.10
$2.52
52주 변동 폭
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
STXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.23 | 193.50M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
What drives Stereotaxis Inc. stock priceTremendous portfolio expansion - jammulinksnews.com
What analysts say about Stereotaxis Inc. stockUnstoppable investment returns - jammulinksnews.com
Is Stereotaxis Inc. a good long term investmentDynamic investment opportunities - printweek.in
Stereotaxis Inc. Stock Analysis and ForecastUnmatched market gains - Autocar Professional
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.5% – What’s Next? - Defense World
Stereotaxis Publishes Positive Results from MAGiC Catheter Study - MSN
Should I buy Stereotaxis Inc. stock before earningsDaily Swing Candidates - Newser
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock - GlobeNewswire
Stereotaxis Sinks on Common Stock Offering - Baystreet.ca
Stereotaxis projects second quarter revenue growth and stable margins By Investing.com - Investing.com South Africa
Stereotaxis raises $12.5 million in registered direct offering By Investing.com - Investing.com Canada
Stereotaxis raises $12.5 million in registered direct offering - Investing.com Australia
Stereotaxis, Inc. Secures $12.5 Million in Registered Direct Offering to Enhance Balance Sheet and Accelerate Product Commercialization - Nasdaq
Surgical Robotics Leader Stereotaxis Lands $12.5M Investment from Strategic Industry Partner - Stock Titan
How Stereotaxis Inc. stock performs during market volatilityFree Daily Stock Market Updates - Newser
Why Concrete Pumping Holdings Inc. stock attracts strong analyst attentionHigh Return Intraday Picks - Newser
What makes Stereotaxis Inc. stock price move sharplyCapital Doubling Tips - Newser
Why Stereotaxis Inc. stock attracts strong analyst attentionFree Investment Portfolio Suggestions - Newser
Stereotaxis Pubishes First Clinical Results from MAGiC Catheter Study - Diagnostic and Interventional Cardiology
Electrophysiology Market is projected to reach USD 22.63 - openPR.com
Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial - MSN
Stereotaxis at an Inflection Point: Catheter Adoption and GenesisX Drive a New Era of Growth - AInvest
Stereotaxis Stock: Recurring Revenue Inflection (NYSE:STXS) - Seeking Alpha
First Clinical Results: Revolutionary MAGiC Robotic Catheter Achieves 94% Success in Heart Arrhythmia Treatment - Stock Titan
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
자본화:
|
볼륨(24시간):